329 related articles for article (PubMed ID: 25424858)
1. SF3B1 mutations constitute a novel therapeutic target in breast cancer.
Maguire SL; Leonidou A; Wai P; Marchiò C; Ng CK; Sapino A; Salomon AV; Reis-Filho JS; Weigelt B; Natrajan RC
J Pathol; 2015 Mar; 235(4):571-80. PubMed ID: 25424858
[TBL] [Abstract][Full Text] [Related]
2. SF3B1 mutations are associated with alternative splicing in uveal melanoma.
Furney SJ; Pedersen M; Gentien D; Dumont AG; Rapinat A; Desjardins L; Turajlic S; Piperno-Neumann S; de la Grange P; Roman-Roman S; Stern MH; Marais R
Cancer Discov; 2013 Oct; 3(10):1122-1129. PubMed ID: 23861464
[TBL] [Abstract][Full Text] [Related]
3. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
Dolatshad H; Pellagatti A; Fernandez-Mercado M; Yip BH; Malcovati L; Attwood M; Przychodzen B; Sahgal N; Kanapin AA; Lockstone H; Scifo L; Vandenberghe P; Papaemmanuil E; Smith CW; Campbell PJ; Ogawa S; Maciejewski JP; Cazzola M; Savage KI; Boultwood J
Leukemia; 2015 May; 29(5):1092-103. PubMed ID: 25428262
[TBL] [Abstract][Full Text] [Related]
4. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.
Makishima H; Visconte V; Sakaguchi H; Jankowska AM; Abu Kar S; Jerez A; Przychodzen B; Bupathi M; Guinta K; Afable MG; Sekeres MA; Padgett RA; Tiu RV; Maciejewski JP
Blood; 2012 Apr; 119(14):3203-10. PubMed ID: 22323480
[TBL] [Abstract][Full Text] [Related]
6. The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.
Larrayoz M; Blakemore SJ; Dobson RC; Blunt MD; Rose-Zerilli MJ; Walewska R; Duncombe A; Oscier D; Koide K; Forconi F; Packham G; Yoshida M; Cragg MS; Strefford JC; Steele AJ
Leukemia; 2016 Feb; 30(2):351-60. PubMed ID: 26488112
[TBL] [Abstract][Full Text] [Related]
7. Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors.
Scott LM; Rebel VI
J Natl Cancer Inst; 2013 Oct; 105(20):1540-9. PubMed ID: 24052622
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.
Alsafadi S; Houy A; Battistella A; Popova T; Wassef M; Henry E; Tirode F; Constantinou A; Piperno-Neumann S; Roman-Roman S; Dutertre M; Stern MH
Nat Commun; 2016 Feb; 7():10615. PubMed ID: 26842708
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
10. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Visconte V; Rogers HJ; Singh J; Barnard J; Bupathi M; Traina F; McMahon J; Makishima H; Szpurka H; Jankowska A; Jerez A; Sekeres MA; Saunthararajah Y; Advani AS; Copelan E; Koseki H; Isono K; Padgett RA; Osman S; Koide K; O'Keefe C; Maciejewski JP; Tiu RV
Blood; 2012 Oct; 120(16):3173-86. PubMed ID: 22826563
[TBL] [Abstract][Full Text] [Related]
11. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.
Harbour JW; Roberson ED; Anbunathan H; Onken MD; Worley LA; Bowcock AM
Nat Genet; 2013 Feb; 45(2):133-5. PubMed ID: 23313955
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
[TBL] [Abstract][Full Text] [Related]
14. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
[TBL] [Abstract][Full Text] [Related]
15. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research.
Samy A; Ozdemir MK; Alhajj R
Sci Rep; 2023 Feb; 13(1):2704. PubMed ID: 36792691
[TBL] [Abstract][Full Text] [Related]
16. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.
Effenberger KA; Anderson DD; Bray WM; Prichard BE; Ma N; Adams MS; Ghosh AK; Jurica MS
J Biol Chem; 2014 Jan; 289(4):1938-47. PubMed ID: 24302718
[TBL] [Abstract][Full Text] [Related]
17. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
[TBL] [Abstract][Full Text] [Related]
18. A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages.
Gentien D; Kosmider O; Nguyen-Khac F; Albaud B; Rapinat A; Dumont AG; Damm F; Popova T; Marais R; Fontenay M; Roman-Roman S; Bernard OA; Stern MH
Leukemia; 2014 Jun; 28(6):1355-7. PubMed ID: 24434863
[No Abstract] [Full Text] [Related]
19. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms.
Cazzola M; Rossi M; Malcovati L;
Blood; 2013 Jan; 121(2):260-9. PubMed ID: 23160465
[TBL] [Abstract][Full Text] [Related]
20. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
Papaemmanuil E; Cazzola M; Boultwood J; Malcovati L; Vyas P; Bowen D; Pellagatti A; Wainscoat JS; Hellstrom-Lindberg E; Gambacorti-Passerini C; Godfrey AL; Rapado I; Cvejic A; Rance R; McGee C; Ellis P; Mudie LJ; Stephens PJ; McLaren S; Massie CE; Tarpey PS; Varela I; Nik-Zainal S; Davies HR; Shlien A; Jones D; Raine K; Hinton J; Butler AP; Teague JW; Baxter EJ; Score J; Galli A; Della Porta MG; Travaglino E; Groves M; Tauro S; Munshi NC; Anderson KC; El-Naggar A; Fischer A; Mustonen V; Warren AJ; Cross NC; Green AR; Futreal PA; Stratton MR; Campbell PJ;
N Engl J Med; 2011 Oct; 365(15):1384-95. PubMed ID: 21995386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
